Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, will become the first location in the Eastern United States to be equipped with the Ablatherm robotic high-intensity focused ultrasound (HIFU) device, which is used for prostate tissue removal.
News and Media : 2015
A Miller School of Medicine alumnus and two current Miller School medical students have produced an educational video for patients with end-stage kidney failure about the benefits of kidney transplantation over long-term dialysis. The video, “Kidney Transplant – A Better Option for Dialysis Patients,” offers a lively, animated take on a serious subject and is available on YouTube in English, Spanish and Creole.
Sylvester Comprehensive Cancer Center pathologist Andrew V. Schally, Ph.D., M.D.h.c. (Multi), D.Sc., whose groundbreaking research into the endocrine system was recognized with a 1977 Nobel Prize, was recently elected a Fellow in the National Academy of Inventors.
Dipen J. Parekh, M.D., a member of Sylvester Comprehensive Cancer Center and Professor and Chairman of the Department of Urology and Director of Robotic Surgery at the University of Miami Miller School of Medicine, was in London on Sunday, October 4, where he received the BJU International – Vattikuti Foundation Robotics Prize. The award was given to honor a paper he and colleagues published in 2014.
For more than two decades, Wendy Peacock went to bed every night fearful of not waking up. Peacock, a type 1 diabetic who suffers from severe hypoglycemia unawareness — an unfelt, and dangerous, drop in blood sugar that could send her into a fog or a faint — worried about slipping into a diabetic coma in her sleep.
Dr. Charles M. Lynne, M.D., recently received the American Urology Association’s 2015 Residents Committee Teaching Award in New Orleans.
Six Miller School of Medicine physician-scientists were recognized for their contributions to cancer research and treatment as part of the Sylvester Comprehensive Cancer Center’s 16th Annual Zubrod Memorial Lecture and Cancer Research Poster Session on May 15. It was the first time multiple faculty awards have been part of the program.
In a groundbreaking laboratory study, a research team at Sylvester Comprehensive Cancer Center has found that a non-toxic oral agent that is also consumed as an over-the-counter dietary supplement in Europe and Asia for improving liver health, is highly effective in both preventing and treating prostate cancer. Additionally the agent was able to halt the metastatic spread of the disease.
More than one million men have a prostate biopsy each year in the United States. The majority of these biopsies show either no prostate cancer or low-risk cancer, meaning the biopsy was unnecessary. The 4Kscore is the solution.